Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular Dystrophy

NCT03433807 is registered in ClinicalTrials.gov with Santhera Pharmaceuticals as lead sponsor.

NCT NCT03433807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular Dystrophy
Lead sponsor
Santhera Pharmaceuticals
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy